13 September 2018
A new report by visiongain predicts that the global vaccine contract manufacturing market will reach $1047.3m in 2019. This forecast and others appear in Vaccine Contract Manufacturing Market Report 2016-2026: Leading Countries, Technologies and Companies, published in December 2015. Visiongain is a business information provider based in London, UK.
Vaccine Contract Manufacturing Market Report 2016-2026: Leading Countries, Technologies and Companies examines the current and future trends in the vaccine contract manufacturing market. Vaccines are a healthcare success, with widespread immunisation eradicating some of the world’s most deadly diseases. The development of new vaccines has historically been limited to a number of large companies due to the high costs involved. However, a growing number of virtual companies and the international demand for new therapeutic vaccines especially, growth in the vaccine contract manufacturing market is accelerating. Another key aspect of the market is the rise of emerging markets as not only a destination for vaccines, but as high quality manufacturing centres for them. While visiongain does not believe this will completely reshape the market, its effects cannot be discounted.
In this report, visiongain examines in detail a number of key national markets (US, Germany, UK, France, Spain, Italy, Japan, China, Russia, Brazil and India), as well as looking at the overall vaccine contract manufacturing market and the key players within it. To give scale to the contract manufacturing business, a global vaccines market forecast is also included. Using visiongain’s experience and market knowledge, as well as a wide variety of sources, forecasts have been built for both national and overall markets, accompanied by text giving a thorough explanation of events thought to shape the market currently and in the future.
Visiongain’s report provides revenue forecasts to 2026 for the vaccine contract manufacturing market and its leading national markets. The report discusses selected leading companies which hold significant shares of the market. These companies include Baxter BioPharma Solutions, Boehringer Ingelheim, Catalent, Charles River Laboratories, IDT Biologika, Lonza, Meridian Life Science, Sigma Aldrich Fine Chemicals (Merck) and Synco Bio Partners.
Vaccine Contract Manufacturing Market Report 2016-2026: Leading Countries, Technologies and Companies adds to visiongain’s range of analytical reports on industries and markets in healthcare.
For an executive summary please contact:
Email: Sara Peerun on firstname.lastname@example.org
Tel: +44 (0) 20 7336 6100
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to email@example.com or call her on +44 (0) 207 336 6100
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. From its head office in London, UK, visiongain produces a range of newsletters, business reports and e-zines covering current affairs and market trends in the Energy, Telecoms, Pharmaceutical, Defence, and Materials sectors.
Visiongain publishes reports produced by its in-house analysts, who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high quality, original analyses to inform their strategic decisions.
Currently, the ATMP market is at a nascent stage and is expected to flourish during near future owing to increasing research and development activities and rising use of ATMP therapy products in treatment areas with low or no alternative treatment options support the market growth
24 November 2020
Increasing prevalence of cardiovascular diseases is increasing demand of biological imaging reagents for the diagnosis and treatment of cardiovascular diseases due to this reason increasing prevalence of cardiovascular diseases is acting as a driver for biological imaging reagent market.
13 November 2020
Hypertensive is the most common disease around the world. However, number of people suffering from hypertensive has increased very significantly from last few years. Hypertensive can occur due to consumption of tobacco, too much salt (sodium) and little potassium in your diet, alcohol and to people being overweight or obese.
13 November 2020
The prevalence of bacterial diseases is significantly growing and expected to continuously rise over the forecast period. Number of bacterial diseases cases are increasing, like, bugs biting, including ticks, mosquitoes, lice and from an infected animal, contaminated food or water.